Corindus Vascular Robotics Inc (CVRS) Short Interest Update
Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) was the recipient of a significant growth in short interest during the month of November. As of November 30th, there was short interest totalling 11,390,423 shares, a growth of 11.2% from the November 15th total of 10,240,051 shares. Approximately 12.4% of the company’s stock are short sold. Based on an average daily volume of 975,311 shares, the short-interest ratio is currently 11.7 days.
Corindus Vascular Robotics (CVRS) traded down $0.07 during trading hours on Monday, reaching $1.15. The company’s stock had a trading volume of 430,907 shares, compared to its average volume of 719,792. Corindus Vascular Robotics has a 52 week low of $0.40 and a 52 week high of $2.25.
Corindus Vascular Robotics (NYSEAMERICAN:CVRS) last released its earnings results on Tuesday, November 7th. The medical equipment provider reported ($0.04) EPS for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.01. Corindus Vascular Robotics had a negative return on equity of 110.93% and a negative net margin of 323.84%. The company had revenue of $2.43 million for the quarter, compared to the consensus estimate of $3.60 million.
A number of research analysts have commented on the company. BidaskClub downgraded Corindus Vascular Robotics from a “hold” rating to a “sell” rating in a report on Wednesday, August 16th. Zacks Investment Research raised Corindus Vascular Robotics from a “hold” rating to a “buy” rating and set a $1.75 target price on the stock in a report on Wednesday, August 23rd. Finally, ValuEngine raised Corindus Vascular Robotics from a “sell” rating to a “hold” rating in a report on Wednesday, August 23rd. Two investment analysts have rated the stock with a sell rating and three have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $2.33.
About Corindus Vascular Robotics
Corindus Vascular Robotics, Inc is engaged in robotic-assisted vascular interventions. The Company’s CorPath System is a medical device that brings robotic-assisted precision to radial, coronary and peripheral procedures. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries.
Receive News & Ratings for Corindus Vascular Robotics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corindus Vascular Robotics Inc and related companies with MarketBeat.com's FREE daily email newsletter.